Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2020

01-06-2020 | Research article

Prevalence of metabolic syndrome using international diabetes federation, National Cholesterol Education Panel- Adult Treatment Panel III and Iranian criteria: results of Tabari cohort study

Authors: Adeleh Bahar, Zahra Kashi, Motahareh Kheradmand, Akbar Hedayatizadeh-Omran, Mahdi Moradinazar, Fatemeh Ramezani, Mahdi Afshari, Mahmood Moosazadeh

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2020

Login to get access

Abstract

Background

Metabolic syndrome is defined by co-incidence of multiple metabolic disorders such as central obesity, high triglycerides, low HDL, hyperglycemia and high blood pressure, which increases the risk of cardiovascular disease and diabetes. The aim of this study was to estimate the prevalence of metabolic syndrome using Adult Treatment Panel III (ATP-III), International Diabetes Federation (IDF) and Iranian criteria in large-scaled population based cohort study and to determine the concordance between these criteria.

Methods

In the present study all information collected in Tabari cohort study(TCS) were utilized. These information were collected using a structural questionnaire and taking blood samples from all the participants. Blood pressure and anthropometric indices were measured for all participants by trained practitioners. Categorical variables were compared using chi-square test. In addition, the quantitative variables were compared between the two the groups using independent t-test. Kappa coefficient was estimated to show the agreement between the results of the three criteria.

Results

The prevalences of Metabolic syndrome were 41.10%(CI 95%:40.10–42.02), 44.60%(CI 95%:43.61–45.54), and 30.80% (CI 95%:29.89–31.69) based on ATPIII, international IDF and IDF Iranian criteria respectively. The Kappa agreement coefficients between Iranian IDF with ATPIII definition and international IDF were estimated as 61.80% and 71.20% in the total population respectively.

Conclusion

Kappa coefficient showed that the Iranian IDF had a good agreement with International IDF and an intermediate agreement with the ATP-III. Considering more emphasis of international and Iranian IDF on waist circumference (WC), a better agreement between these two criteria is plausible. Regarding the high prevalence of abdominal obesity among Iranian population, applying these criteria to identify high risk persons might be helpful.
Literature
1.
go back to reference Grundy SM. Metabolic syndrome update. Trends in cardiovascular medicine. 2016;26(4):364–73.CrossRef Grundy SM. Metabolic syndrome update. Trends in cardiovascular medicine. 2016;26(4):364–73.CrossRef
3.
go back to reference Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014. Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014.
4.
go back to reference Rigo JC, Vieira JL, Dalacorte RR, Reichert CL. Prevalence of metabolic syndrome in an elderly community: comparison between three diagnostic methods. Arq Bras Cardiol. 2009;93(2):85–91.CrossRef Rigo JC, Vieira JL, Dalacorte RR, Reichert CL. Prevalence of metabolic syndrome in an elderly community: comparison between three diagnostic methods. Arq Bras Cardiol. 2009;93(2):85–91.CrossRef
5.
go back to reference Hajian-Tilaki K, Heidari B, Firouzjahi A, Bagherzadeh M, Hajian-Tilaki A, Halalkhor S. Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2014;8(3):170–6.CrossRef Hajian-Tilaki K, Heidari B, Firouzjahi A, Bagherzadeh M, Hajian-Tilaki A, Halalkhor S. Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2014;8(3):170–6.CrossRef
6.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–52.CrossRef Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–52.CrossRef
7.
go back to reference Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62.CrossRef Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62.CrossRef
8.
go back to reference Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of obesity. Archives of Iranian medicine. 2010;13(5):426–8.PubMed Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of obesity. Archives of Iranian medicine. 2010;13(5):426–8.PubMed
9.
go back to reference Organization WH. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008. 2011. Organization WH. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008. 2011.
10.
go back to reference O'neill S, O'driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12.CrossRef O'neill S, O'driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12.CrossRef
11.
go back to reference Ostovar R, Kiani F, Sayehmiri F, Yasemi M, Mohsenzadeh Y, Mohsenzadeh Y. Prevalence of metabolic syndrome in Iran: a meta-analysis. Electron Physician. 2017;9(10):5402–18.CrossRef Ostovar R, Kiani F, Sayehmiri F, Yasemi M, Mohsenzadeh Y, Mohsenzadeh Y. Prevalence of metabolic syndrome in Iran: a meta-analysis. Electron Physician. 2017;9(10):5402–18.CrossRef
12.
go back to reference Nolan PB, Carrick-Ranson G, Stinear JW, Reading SA, Dalleck LC. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: a pooled analysis. Prev Med Rep. 2017;7:211–5.CrossRef Nolan PB, Carrick-Ranson G, Stinear JW, Reading SA, Dalleck LC. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: a pooled analysis. Prev Med Rep. 2017;7:211–5.CrossRef
13.
go back to reference Kheradmand MMM, Saeedi M, Poustchi H, Eghtesad S. Tabari cohort study profile and first results in urban and mountainous regions, Mazandaran. Iran Archives of Iranian medicine. 2019. Kheradmand MMM, Saeedi M, Poustchi H, Eghtesad S. Tabari cohort study profile and first results in urban and mountainous regions, Mazandaran. Iran Archives of Iranian medicine. 2019.
14.
go back to reference Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN cohort study): rationale, objectives, and design. Am J Epidemiol. 2017;187(4):647–55.CrossRef Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN cohort study): rationale, objectives, and design. Am J Epidemiol. 2017;187(4):647–55.CrossRef
15.
go back to reference Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E, Joukar F, Hamzeh B, et al. The PERSIAN cohort: providing the evidence needed for healthcare reform. Archives of Iranian medicine. 2017;20(11):691–5.PubMed Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E, Joukar F, Hamzeh B, et al. The PERSIAN cohort: providing the evidence needed for healthcare reform. Archives of Iranian medicine. 2017;20(11):691–5.PubMed
17.
go back to reference Amirkalali B, Fakhrzadeh H, Sharifi F, Kelishadi R, Zamani F, Asayesh H, et al. Prevalence of metabolic syndrome and its components in the Iranian adult population: a systematic review and meta-analysis. Iranian Red Crescent Medical Journal. 2015;17(12). Amirkalali B, Fakhrzadeh H, Sharifi F, Kelishadi R, Zamani F, Asayesh H, et al. Prevalence of metabolic syndrome and its components in the Iranian adult population: a systematic review and meta-analysis. Iranian Red Crescent Medical Journal. 2015;17(12).
18.
go back to reference Dalvand S, Niksima SH, Meshkani R, Ghanei Gheshlagh R, Sadegh-Nejadi S, Kooti W, et al. Prevalence of metabolic syndrome among Iranian population: a systematic review and meta-analysis. Iran J Public Health. 2017;46(4):456–67.PubMedPubMedCentral Dalvand S, Niksima SH, Meshkani R, Ghanei Gheshlagh R, Sadegh-Nejadi S, Kooti W, et al. Prevalence of metabolic syndrome among Iranian population: a systematic review and meta-analysis. Iran J Public Health. 2017;46(4):456–67.PubMedPubMedCentral
19.
go back to reference Ramli AS, Daher AM, Nor-Ashikin MN, Mat-Nasir N, Ng KK, Miskan M, et al. JIS definition identified more Malaysian adults with metabolic syndrome compared to the NCEP-ATP III and IDF criteria. Biomed Res Int. 2013;2013:760963.CrossRef Ramli AS, Daher AM, Nor-Ashikin MN, Mat-Nasir N, Ng KK, Miskan M, et al. JIS definition identified more Malaysian adults with metabolic syndrome compared to the NCEP-ATP III and IDF criteria. Biomed Res Int. 2013;2013:760963.CrossRef
20.
go back to reference Luksiene DI, Baceviciene M, Tamosiunas A, Reklaitiene R, Radisauskas R. Comparison of four definitions of the metabolic syndrome and odds of ischemic heart disease in the Lithuanian urban population. Int J Public Health. 2012;57(3):543–50.CrossRef Luksiene DI, Baceviciene M, Tamosiunas A, Reklaitiene R, Radisauskas R. Comparison of four definitions of the metabolic syndrome and odds of ischemic heart disease in the Lithuanian urban population. Int J Public Health. 2012;57(3):543–50.CrossRef
21.
go back to reference Houti L, Hamani-Medjaoui I, Lardjam-Hetraf SA, Ouhaibi-Djellouli H, Chougrani S, Goumidi L, et al. Prevalence of metabolic syndrome and its related risk factors in the City of Oran, Algeria: the ISOR study. Ethnicity & disease. 2016;26(1):99–106.CrossRef Houti L, Hamani-Medjaoui I, Lardjam-Hetraf SA, Ouhaibi-Djellouli H, Chougrani S, Goumidi L, et al. Prevalence of metabolic syndrome and its related risk factors in the City of Oran, Algeria: the ISOR study. Ethnicity & disease. 2016;26(1):99–106.CrossRef
22.
go back to reference Sharifi F, Mousavinasab S, Saeini M, Dinmohammadi M. Prevalence of metabolic syndrome in an adult urban population of the west of Iran. Exp Diabetes Res. 2009;2009. Sharifi F, Mousavinasab S, Saeini M, Dinmohammadi M. Prevalence of metabolic syndrome in an adult urban population of the west of Iran. Exp Diabetes Res. 2009;2009.
23.
go back to reference Gonzalez-Ortiz M, Martinez-Abundis E, Jacques-Camarena O, Hernandez-Gonzalez SO, Valera-Gonzalez IG, Ramos-Zavala MG. Prevalence of metabolic syndrome in adults with excess of adiposity: comparison of the adult treatment panel III criteria with the international diabetes federation definition. Acta Diabetol. 2006;43(3):84–6.CrossRef Gonzalez-Ortiz M, Martinez-Abundis E, Jacques-Camarena O, Hernandez-Gonzalez SO, Valera-Gonzalez IG, Ramos-Zavala MG. Prevalence of metabolic syndrome in adults with excess of adiposity: comparison of the adult treatment panel III criteria with the international diabetes federation definition. Acta Diabetol. 2006;43(3):84–6.CrossRef
24.
go back to reference Misra A, Wasir JS, Vikram NK. Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. Nutrition. 2005;21(9):969–76.CrossRef Misra A, Wasir JS, Vikram NK. Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. Nutrition. 2005;21(9):969–76.CrossRef
25.
go back to reference Esteghamati A, Ashraf H, Rashidi A, Meysamie A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract. 2008;82(1):104–7.CrossRef Esteghamati A, Ashraf H, Rashidi A, Meysamie A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract. 2008;82(1):104–7.CrossRef
26.
go back to reference Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO. Prevalence of metabolic syndrome according to adult treatment panel III and international diabetes federation criteria: a population-based study. Metab Syndr Relat Disord. 2009;7(3):221–9.CrossRef Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO. Prevalence of metabolic syndrome according to adult treatment panel III and international diabetes federation criteria: a population-based study. Metab Syndr Relat Disord. 2009;7(3):221–9.CrossRef
27.
go back to reference Guerrero-Romero F, Rodriguez-Moran M. Concordance between the 2005 international diabetes federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care. 2005;28(10):2588–9.CrossRef Guerrero-Romero F, Rodriguez-Moran M. Concordance between the 2005 international diabetes federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care. 2005;28(10):2588–9.CrossRef
28.
go back to reference Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007;77(2):251–7.CrossRef Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007;77(2):251–7.CrossRef
Metadata
Title
Prevalence of metabolic syndrome using international diabetes federation, National Cholesterol Education Panel- Adult Treatment Panel III and Iranian criteria: results of Tabari cohort study
Authors
Adeleh Bahar
Zahra Kashi
Motahareh Kheradmand
Akbar Hedayatizadeh-Omran
Mahdi Moradinazar
Fatemeh Ramezani
Mahdi Afshari
Mahmood Moosazadeh
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2020
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00492-6

Other articles of this Issue 1/2020

Journal of Diabetes & Metabolic Disorders 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.